Brian Hahn, GlycoMimetics, Inc. CFO and BIO Finance & Tax Committee Co-Chair, provided testimony on behalf of BIO before House Subcommittee on Capital Markets and Government Sponsored Enterprises in support of Fostering Innovation Act, which would extend JOBS Act's SOX Section 404(b) exemption. Hahn also provided support for SEC Small Business Advocate Act and Small Business Capital Formation Enhancement Act, which would enhance role of emerging companies in SEC's policymaking process.